Updated Jul 16, 2026
Mack David Henry is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $62K.
David Henry Mack is the President and CEO of PMV Pharmaceuticals, Inc., a company focused on developing precision oncology therapies targeting p53 mutations. He has been involved in the company's operations as indicated by his role and SEC filings.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | S — Open-market sale | 58.4K | $1.06 | $62K |
David Henry Mack is the President and CEO of PMV Pharmaceuticals, Inc., a company focused on developing precision oncology therapies targeting p53 mutations. He has been involved in the company's operations as indicated by his role and SEC filings.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($62K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mack David Henry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.